project id: TCGA-LUAD; case submitter id: TCGA-MP-A4T8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 68; days to birth: -25069; days to death: 161; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1938; year of death: 2006; age at diagnosis: 25069; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 2352; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-MP-A4T8-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 30.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;